The first 768 thousand vaccines from Sinopharm, of a total of 24 million that the Argentine Government acquired from China, They will arrive in the afternoon of this Sunday from Beijing on a plane Argentinian airlines, within the framework of an operation that will involve the daily arrival of flights throughout the week to combat the advance of the coronavirus.
The Airbus 330-200, which took off from Ezeiza International Airport last Friday, is scheduled to land on Argentine soil around 6:00 p.m., with the first shipment of 768 thousand doses.
From Wednesday 7, meanwhile, successive flights will begin to take off daily until Thursday 15.
The returns of these flights are scheduled every day between Friday 9 and Saturday 17, date on which the last of this first stage will arrive, completing at that time the first eight million doses of vaccines Sinopharm acquired in China.
Argentina closed an agreement to receive 24 million doses of Sinopharm between July and September. Photo: Xinhua
–
This diagram is part of the new agreement that Argentina signed with the Chinese laboratory to purchase another 24 million vaccines. Then it is planned to receive 8 million in August and the same amount in September. So far, the country received 6 million of this brand.
While waiting for the arrival of this large flow of doses, in the country the possibility of combining different vaccines begins to be evaluated to compensate for the low availability of component 2 of Sputnik V.
The issue was discussed on Wednesday at the meeting of the National Immunization Commission (CoNaIn), while the City of Buenos Aires will conduct its own investigation to analyze which Covid-19 vaccine Sputnik V can be combined with.
According to a survey carried out by the Ministry of Health, which was presented at the CoNaIn meeting, of the three vaccines that are being applied in Argentina, Sinopharm is the one with the least effectiveness.
Thus, after the application of the first dose Sputnik V achieved an effectiveness of 74%, AstraZeneca reached 79.5% and Sinopharm was 61.6%.
With the complete immunization schedule – that is, with the two injections – the effectiveness rose to 93.3% with Sputnik V, 88.8% with AstraZeneca and 84% with Sinopharm.
So far, a total of 26,847,730 doses have arrived in the country, of which 11,265,830 correspond to Sputnik V (9,375,670 from component 1 and 1,890,160 from component 2), six million from Sinopharm; 580,000 to AstraZeneca-Covishield, 1,944,000 to AstraZeneca through the COVAX mechanism of the WHO, and 7,057,900 to those of AstraZeneca and Oxford whose active principle was produced in Argentina.
DD
